{
    "title": "Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml",
    "link": "https://www.medscape.com/cx/rssfeeds/2700.xml",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-06-08T02:36:16.827416",
    "items": [
        {
            "title": "Pegcetacoplan Maintains Kidney Benefits at 52 Weeks",
            "link": "https://www.medscape.com/viewarticle/pegcetacoplan-maintains-kidney-benefits-52-weeks-2025a1000fd7?src=rss",
            "description": "Significant reductions in proteinuria, estimated glomerular filtration rate stability of the C3/C3b inhibitor were also observed in key subgroups, inc...",
            "pubDate": "2025-06-08T01:40:36",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        },
        {
            "title": "Limited Survival Benefit With Expanded Kidney Donor Criteria",
            "link": "https://www.medscape.com/viewarticle/limited-survival-benefit-expanded-kidney-donor-criteria-2025a1000fd5?src=rss",
            "description": "The universal survival benefit with kidney transplant over dialysis does not apply to older and high-risk patients receiving an expanded criteria orga...",
            "pubDate": "2025-06-07T18:58:37",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        },
        {
            "title": "Sibeprenlimab Halves uPCR in IgA Nephropathy Trial",
            "link": "https://www.medscape.com/viewarticle/sibeprenlimab-halves-upcr-iga-nephropathy-trial-2025a1000fcm?src=rss",
            "description": "The novel selective antibody sibeprenlimab reduced proteinuria more than any prior drug for IgA nephropathy, with excellent safety outcomes, interim p...",
            "pubDate": "2025-06-06T19:43:07",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png"
        },
        {
            "title": "Nefecon Shows IgAN Benefits Regardless of Baseline eGFR",
            "link": "https://www.medscape.com/viewarticle/nefecon-shows-igan-benefits-regardless-baseline-egfr-2025a1000fcd?src=rss",
            "description": "A subanalysis of the NeflgArd study shows benefits in eGFR and urine protein-creatinine ratio at baseline and across timepoints, regardless of baselin...",
            "pubDate": "2025-06-06T19:08:11",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png"
        },
        {
            "title": "Canagliflozin CV Benefits Appear to Be Dose-Dependent",
            "link": "https://www.medscape.com/viewarticle/canagliflozin-cv-benefits-appear-be-dose-dependent-2025a1000fby?src=rss",
            "description": "A post-hoc analysis of the pivotal CANVAS trial shows those receiving higher dose canagliflozin are more likely to experience the cardiovascular benef...",
            "pubDate": "2025-06-06T18:00:40",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png"
        }
    ]
}